Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial
替沃扎尼与索拉非尼作为转移性肾细胞癌患者初始靶向治疗的比较:一项 III 期试验的结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2012.47.4940
Motzer, Robert J; Nosov, Dmitry; Eisen, Timothy; Bondarenko, Igor; Lesovoy, Vladimir; Lipatov, Oleg; Tomczak, Piotr; Lyulko, Oleksiy; Alyasova, Anna; Harza, Mihai; Kogan, Mikhail; Alekseev, Boris Y; Sternberg, Cora N; Szczylik, Cezary; Cella, David; Ivanescu, Cristina; Krivoshik, Andrew; Strahs, Andrew; Esteves, Brooke; Berkenblit, Anna; Hutson, Thomas E